Bentham Science Logo

S.No. Title Source Title Authors DOI Citing Works Count
1 A Self-administered Version of the Functioning Assessment Short Test for Use in Population-based Studies: A Pilot Study Clinical Practice And Epidemiology In Mental Health : CP & EMH Christoph Riegler; Silke Wiedmann; Viktoria Rücker; Henning Teismann; Klaus Berger; Stefan Störk; Eduard Vieta; Hermann Faller; Bernhard T. Baune; Peter U. Heuschmann 10.2174/1745017902016010192 0
2 Tacrolimus - Pharmacokinetic Considerations for Clinicians. Current Drug Metabolism Katharina Schütte-Nütgen; Gerold Thölking; Barbara Suwelack; Stefan Reuter 10.2174/1389200219666180101104159 23
3 The Rule of Histology in the Diagnosis of Periprosthetic Infection: Specific Granulocyte Counting Methods and New Immunohistologic Staining Techniques may Increase the Diagnostic Value The Open Orthopaedics Journal Friedrich Boettner; Gabriele Koehler; Alexander Wegner; Tom Schmidt-Braekling; Georg Gosheger; Christian Goetze 10.2174/1874325001610010457 8
4 Prognostic Implications of Immunohistochemical Biomarkers in Non-Muscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer Mini-reviews In Medicinal Chemistry Martin Boegemann; Laura-Maria Krabbe 6
5 Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection. Current Pharmaceutical Design Bianca Menchicchi; Andreas Hensel; Francisco M. Goycoolea 10.2174/1381612821666150820104028 13
6 Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation Current Protein & Peptide Science Archana Kumar; Sampath Kumar Katakam; Ann-Kathrin Urbanowitz; Martin Götte 10.2174/1573402111666150213165054 36
7 The Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure Current Medicinal Chemistry Jan S. Schulte; Matthias D. Seidl; Frank U. Müller 10.2174/09298673113209990172 1
8 Differences in saccadic eye movements in subjects at high and low risk for panic disorder. Current Pharmaceutical Design Peter Zwanzger; Jacques Bradwejn; Julia Diemer; Roger W. Marshall; Diana Koszycki 10.2174/138161212803530934 3
9 Immune Therapy of Multiple Sclerosis - Future Strategies Current Pharmaceutical Design Sven G. Meuth; Kerstin Göbel; Heinz Wiendl 10.2174/138161212802502198 22
10 Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems. Current Medicinal Chemistry Sandra Cramer; Ralf Rempe; Hans-Joachim Galla 10.2174/092986712800784711 10
11 The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases - Part II Current Medicinal Chemistry Thomas J. Schmidt; Sami A. Khalid; Alvaro J. Romanha; T. Ma. Alves; Maique W. Biavatti; Reto Brun; FB Da Costa; S. L. De Castro; Vitor F. Ferreira; M. V. G. de Lacerda; João Henrique G. Lago; L. L. Leon; Norberto Peporine Lopes; R. C. das Ne 10.2174/092986712800229023 176
12 Emerging Treatment Strategies and Potential Therapeutic Targets in Primary Sjogrens Syndrome Inflammation & Allergy Drug Targets H. Becker; Hermann Pavenstaedt; P. Willeke 10.2174/187152810791292935 11
13 Multiple roles of the extracellular matrix in inflammation. Current Pharmaceutical Design Eva Korpos; Chuan Wu; Lydia Sorokin 10.2174/138161209787846685 71
14 GABAergic and endocannabinoid dysfunction in anxiety - future therapeutic targets? Current Pharmaceutical Design Katharina Domschke; Peter Zwanzger 10.2174/138161208786848784 37
15 Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells Current Cancer Drug Targets Konstantin Agelopoulos; H. Buerger; B. Brandt 10.2174/156800908785133213 19
16 Targeted therapies in breast cancer: established drugs and recent developments. Current Clinical Pharmacology Jeanett Fischgräbe; Pia Wülfing 10.2174/157488408784293732 23
17 Generation of fusion proteins for selective occlusion of tumor vessels. Current Drug Discovery Technologies Rolf M. Mesters; Torsten Kessler; Christian Schwöppe; Ruediger Liersch; Christoph Schliemann; Heike Hintelmann; Ralf Bieker; Wolfgang E. Berdel 10.2174/157016308783769487 30
18 Preclinical testing of drug-induced proarrhythmia: value of transgenic models. Cardiovascular & Hematological Agents In Medicinal Chemistry Larissa Fabritz; G. Breithardt; Paulus Kirchhof 10.2174/187152507782109881 4
19 The endothelin axis: a novel target for pharmacotherapy of female malignancies. Current Vascular Pharmacology M. Smollich; Pia Wülfing 10.2174/157016107781024082 41
20 Oncogenic signaling in acute myeloid leukemia. Current Drug Targets Christian Brandts; Wolfgang E. Berdel; Hubert Serve 10.2174/138945007779940197 10
21 Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies Current Drug Targets Torsten Kessler; Frauke Fehrmann; Ralf Bieker; Wolfgang E. Berdel; Rolf M. Mesters 10.2174/138945007779940089 44
22 Recently Patented Applications of Homologous Cellular and Extracellular Agents as Therapeutics or Targets for the Prevention of Restenosis Post- Angioplasty Recent Patents On Cardiovascular Drug Discovery Rainer Klocke; Lekbira Hasib; Sigrid Nikol 10.2174/157489006775244272 5
23 Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging. Current Medicinal Chemistry Bernd Tombach; Peter Reimer 10.2174/092986705774462932 4
24 Epileptogenicity and epileptic activity: mechanisms in an invertebrate model nervous system. Current Drug Targets U. Altrup 10.2174/1389450043345344 9
25 Regulation of the immune response by natural IgM: lessons from warm autoimmune hemolytic anemia. Current Pharmaceutical Design Dorothea Stahl; Walter Sibrowski 10.2174/1381612033454397 8
Webmaster Contact:
Copyright © 2020 Bentham Science